APA (7th ed.) Citation

L, Z., R, M., I, C., F, G., S, G., F, V., . . . M, F. (2024). Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real-life study. European journal of neurology, 31(12), e16410. https://doi.org/10.1111/ene.16410

Chicago Style (17th ed.) Citation

L, Zanandrea, et al. "Effectiveness and Safety of Monthly Versus Quarterly Fremanezumab for Migraine Prevention: An Italian, Multicenter, Real-life Study." European Journal of Neurology 31, no. 12 (2024): e16410. https://doi.org/10.1111/ene.16410.

MLA (9th ed.) Citation

L, Zanandrea, et al. "Effectiveness and Safety of Monthly Versus Quarterly Fremanezumab for Migraine Prevention: An Italian, Multicenter, Real-life Study." European Journal of Neurology, vol. 31, no. 12, 2024, p. e16410, https://doi.org/10.1111/ene.16410.